Brief: Unicycive Therapeutics Announces Q3 Loss Per Share Of $0.37

Unicycive Therapeutics

11/11/2021 14:19

Nov 11 (Reuters) - Unicycive Therapeutics Inc  UNCY.O :
    * UNICYCIVE THERAPEUTICS ANNOUNCES THIRD QUARTER 2021
FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $0.37
    * AS OF SEPTEMBER 30, 2021, CASH AND CASH EQUIVALENTS
TOTALED $18
MILLION
    * EXPECT TO RECEIVE CONFIRMATORY GUIDANCE ON RENAZORB
REGULATORY
PATHWAY FROM FDA IN Q4 2021
    * PLANNED COMPLETION OF PRE-CLINICAL STUDIES WITH UNI-494 IN
FIRST
HALF OF 2022

Source text for Eikon:  ID:nPn9D5wG5a 
Further company coverage:  UNCY.O 

 ((Reuters.Briefs@thomsonreuters.com;))